Impact of prostate volume on the active surveillance in prostate cancer

被引:0
|
作者
Beaujouan, Florent [1 ]
Bertherat, Walter [2 ]
Hammoudi, Zakaria [1 ]
Chicaud, Marie [1 ]
Descazeaud, Aurelien [1 ]
机构
[1] Univ Hosp Ctr Dupuytren, Dept Urol Surg & Androl, 16 rue Petiniaud-Beaupeyrat, F-87000 Limoges, France
[2] Perigueux Hosp Ctr, Dept Urol Surg & Androl, Perigueux, France
关键词
Prostatic neoplasms; active surveillance; prostate-specific antigen; prostatic hyperplasia; prognostic factors; FOLLOW-UP; ANTIGEN KINETICS; GUIDELINES; MANAGEMENT; DIAGNOSIS; OUTCOMES; PREDICT; UPDATE; BIOPSY; COHORT;
D O I
10.1177/20514158241303972
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the influence of the prostate volume (PVo) in the management of patients in active surveillance (AS) for prostate cancer. Materials and methods: A retrospective analysis of clinical, biological, histological and radiological data collected between 2010 and 2021 was performed for patients included in an AS protocol in a university hospital. The impact of initial PVo on the subsequent risk of exiting AS was evaluated. Results: In total, 109 patients were included in this analysis with a mean follow-up period of 52.74 +/- 31 months, 50% were out of AS by the end of the follow-up period. The risk of exiting the AS protocol was significantly associated to the PVo: patients with smaller PVo had an increased risk of exiting AS (p = 0.025). The maximal percentage of core invasion was the only initial predictive parameter for exiting the AS protocol on multivariate analysis of the global cohort (p = 0.010) and in the sub-group of patients having PVo <= 45 mL (p = 0.013). In the group having a PVo > 45 mL, no single initial parameter was significantly associated to a risk of exiting AS. Conclusion: Patients having small-sized prostate seemed to be at higher risk of exiting AS during follow-up.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Active Surveillance for Prostate Cancer: Past, Current, and Future Trends
    de Vos, Ivo I.
    Luiting, Henk B.
    Roobol, Monique J.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):
  • [22] Conditional Probability of Reclassification in an Active Surveillance Program for Prostate Cancer
    Alam, Ridwan
    Carter, H. Ballentine
    Landis, Patricia
    Epstein, Jonathan I.
    Mamawala, Mufaddal
    JOURNAL OF UROLOGY, 2015, 193 (06) : 1950 - 1955
  • [23] Active surveillance for prostate cancer: a narrative review of clinical guidelines
    Bruinsma, Sophie M.
    Bangma, Chris H.
    Carroll, Peter R.
    Leapman, Michael S.
    Rannikko, Antti
    Petrides, Neophytos
    Weerakoon, Mahesha
    Bokhorst, Leonard P.
    Roobol, Monique J.
    NATURE REVIEWS UROLOGY, 2016, 13 (03) : 151 - 167
  • [24] Changes in Cancer Volume in Serial Biopsies of Men on Active Surveillance for Early Stage Prostate Cancer
    Porten, Sima P.
    Whitson, Jared M.
    Cowan, Janet E.
    Perez, Nannette
    Shinohara, Katsuto
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2011, 186 (05) : 1825 - 1829
  • [25] Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitatspartnerschaft Urologie (QuapU)
    Eredics, Klaus
    Dorfinger, Karl
    Kramer, Gero
    Ponholzer, Anton
    Madersbacher, Stephan
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 (11-12) : 375 - 379
  • [26] Active surveillance for localized prostate cancer
    Staerman, F.
    Peyromaure, M.
    Irani, J.
    Gaschignard, N.
    Mottet, N.
    Soulie, M.
    Salomon, L.
    PROGRES EN UROLOGIE, 2011, 21 (07): : 448 - 454
  • [27] Active surveillance for localized prostate cancer
    Drouin, S. J.
    Roupret, M.
    Hamdy, F.
    Mottet, N.
    PROGRES EN UROLOGIE, 2010, 20 : S181 - S185
  • [28] The Evolution of Active Surveillance for Prostate Cancer
    Moore, Caroline M.
    Parker, Chris
    EUROPEAN UROLOGY, 2015, 68 (05) : 822 - 823
  • [29] The Relationship Between Prostate Specific Antigen Change and Biopsy Progression in Patients on Active Surveillance for Prostate Cancer
    Whitson, Jared M.
    Porten, Sima P.
    Hilton, Joan F.
    Cowan, Janet E.
    Perez, Nannette
    Cooperberg, Matthew R.
    Greene, Kirsten L.
    Meng, Maxwell V.
    Simko, Jeff P.
    Shinohara, Katsuto
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2011, 185 (05) : 1656 - 1660
  • [30] Super active surveillance for low-risk prostate cancer | Opinion: No
    Ghodoussipour, Saum
    Lebastchi, Amir
    Pinto, Peter
    Berger, Andre
    INTERNATIONAL BRAZ J UROL, 2019, 45 (02): : 215 - 219